ATR-FTIR Spectroscopy Evaluated on Breast Tissue, Tumors
A recent study demonstrated that ATR-FTIR spectroscopy can accurately differentiate normal, benign, and malignant breast tissues.
Tag: cancer diagnostics
All
Latest
All
Latest
New AI Model Achieves 94% Accuracy in Skin Cancer Diagnostics
A new study introduced an AI-powered diagnostic model with 94.49% accuracy to improve skin cancer detection and patient outcomes.
All
Latest
NCCN Genetic Testing Guidelines Expanded for High-Risk Cancer Assessment
The NCCN updated its Clinical Practice Guidelines to broaden genetic testing recommendations for high-risk cancer types.
New Blood Test Improves Early Pancreatic Cancer Detection by 27%
An experimental test detects early-stage pancreatic cancer more effectively than current tests via a combination of two sugar biomarkers.
Read More
AI-Powered Blood Test Enhances Early Detection of Ovarian Cancer
An AI-powered blood test combining DNA fragment analysis with protein biomarkers significantly improves early ovarian cancer detection.
Read More
How Blood-Based Biofluid Testing Is Revolutionizing Cancer Diagnostics
We discussed with Courtney Noah, PhD, of BioIVT, about how blood-based biofluid testing is poised to revolutionize cancer diagnostics.
Read More
New Ibex Report Highlights Patient Concerns About Cancer Diagnoses
Ibex Medical Analytics’ inaugural Patient Insight Report on Cancer Diagnostics reveals widespread concerns about cancer diagnoses.
Read More
​​Researchers Call for Scrutiny of Genetic Panel Testing in Cancer Diagnostics
A Yale study suggests that comprehensive gene panel testing requires greater evaluation to determine their true impact on cancer diagnostics.
Read More
Data Shows Decrease in Cancer and Disease Diagnoses Continued in Pandemic’s Second Year
Dancer diagnoses in the U.S. remained below pre-pandemic levels in 2021, with fewer early-stage and late-stage diagnoses compared to 2020.
Read More
Roche Expands Digital Pathology Platform with AI-Driven Algorithms
Roche’s navify digital pathology enterprise software now integrates a range of AI-driven algorithms, enabling enhanced cancer diagnostics.
Read More
Roche Adds AI-Powered Solution to its Digital Pathology Platform
Qritive has partnered with Roche to integrate its AI-powered cancer diagnostic tools with the Roche navify Digital Pathology platform.
Read More
Sophia Genetics and AstraZeneca Partner to Develop Liquid Biopsy Cancer Test
SOPHiA GENETICS and AstraZeneca will expand the reach of the MSK-ACCESS liquid biopsy test to enhance cancer diagnostics options.
Read More
New Cancer Gene Detection Tech Achieves High Sensitivity
Researchers developed a new nanomaterial-based technology that detects cancer mutant genes in blood with unparalleled sensitivity.
Read More
A New Artificial Intelligence Tool for Cancer DiagnosisÂ
A new AI model is capable of diagnosing multiple types of cancer, predicting patient survival, and identifying tumor molecular profiles.
Read More
Universal DX Initiates Clinical Trial for FDA Approval of Colorectal Cancer Test
Universal DX initiated a clinical trial for its colorectal cancer screening blood test with the goal of achieving FDA premarket approval.
Read More
Researchers Discover Novel Nanoparticles in Blood that Could Transform Cancer Diagnosis
A newly discovered class of RNA molecules in extracellular vesicles could serve as biomarkers for non-invasive cancer diagnosis.
Read More
Ways2Well Selects Cancer Check Labs as its Provider of Early Cancer Detection Test
Cancer Check Labs has been chosen as the exclusive provider of early cancer detection tests for Ways2Well, a regenerative medicine clinic.
Read More
Prostate Cancer: Is AI the Answer to Limit Need of Biopsies?
A retrospective study shows that combining risk markers, MRI evaluation, and AI can more accurately predict prostate cancer risk.
Read More